Statistics for Cannara Biotech Inc. (id:1174 LOVE)
Valuation metrics
Market cap
61.21M
Enterprise value
104.63M
Trailing P/E (ttm)
9.71
Forward P/E
PEG ratio
Price/Sales (ttm)
3.00
Price/Book (mrq)
3.00
Enterprise Value/Revenue
1.36
Enterprise Value/EBITDA
7.32
Overview
Shares outstanding
90.02M
Float
43.99M
Shares short
10.00
% Held by insiders
3.00%
% Held by institutions
0.00%
Average volume (10 days)
15.10K
Average volume (90 days)
Price summary
52-Week low
3.00
52-Week high
1.04
52-Week change
-18.57%
Beta
1.07
50-Day moving average
3.00
200-Day moving average
3.00
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
February 13, 2023
Financials
Fiscal yearFiscal year ends
August 31, 2023
Most recent quarter (mrq)
August 31, 2024
Profitability
Profit margin
6.93%
Operating margin
7.75%
Operational effectiveness
Return on assets
3.78%
Return on equity
6.78%
Income statement
Revenue (ttm)
3.00
Revenue per share (ttm)
3.00
Quarterly revenue growth (yoy)
3.00
Gross profit (ttm)
29.79M
EBITDA
13.25M
Net income to common (ttm)
5.32M
Diluted EPS (ttm)
5.00
Quarterly earnings growth (yoy)
-30.90%
Balance sheet
Total cash (mrq)
5.46M
Total cash per share (mrq)
5.00
Total debt (mrq)
48.88M
Total Debt/Equity (mrq)
59.78
Current ratio (mrq)
231.60%
Book value per share (mrq)
3.00
Cash flow
Cash flow statement
9.91M
Levered free cash flow (LFCF)
-10,362,264.00